SYNVISC ONE 48mg / 6ml x 1 pre-filled syringe

Genzyme Europe BV


£399.99 £700.00




 
  • SYNVISC ONE is a formulation that nourishes joints and relieves pain associated with joint injuries. SYNVISC ONE is characterized by the properties of synovial fluid and is used to periodically replace and supplement it.

Composition SYNVISC ONE :
1ml of hylan GF 20 contains: hylan 8.0mg, sodium chloride 8.5mg, disodium hydrogenphosphate 0.16mg, sodium triphosphate monohydrate 0.04mg, water for injection qs

SYNVISC ONE Action:
Preparation for local use with complex composition. It is characterized by the properties of synovial fluid and is used to periodically replace and supplement it. Contains ingredients that provide joint flexibility and excellent lubrication. Hylan is a derivative of hyaluronic acid, which is a natural component of joint synovial fluid. This ensures the maintenance of viscosity and lubrication of the joints. The use of the preparation helps nourish joint structures and relieve pain associated with injuries. The action of the preparation consists in viscosupplementation - a process in which the physiological and rheological state of the changed inflammation of the tissues of the knee is restored.

Contraindications SYNVISC ONE :
- Sensitization to the components of the preparation 
- Infection, inflammation of the joint 
- Infection, skin disease occurring at the injection site 
- Venous or lymphatic stasis

SYNVISC ONE Indications: The product should be used to periodically replace and replenish the synovial fluid. Recommended for people in all stages of joint disease.

Dosage SYNVISC ONE :
Use topical, intradominal. Apply one injection to the knee joint. In justified cases, repeat operation after 6 months.